Vaccine Looks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

has also been studying a three-dose vaccine series. well, data on the three dose has been coming in pretty quickly. and the fda decided, you know what, let s postpone a meeting of our vaccine advisers, let s postpone our consideration of this vaccine authorization until the three-dose data come in. that way the agency has a full, complete dataset on what this vaccine looks like when it comes to efficacy when you look at three doses compared to two doses. so that s what happened, brianna. that s what we re seeing. pfizer expects to have its data on three doses in early april. so possibly around then is when we can see this consideration of authorizing the vaccine continue. but of course many parents are frustrated. but, again, brianna, this is all about having complete data on efficacy and hopefully we can see the discussions resume in the coming months. so if that happens, jacqueline, in early april, what is the estimate, the soonest we

Vaccine advisersVaccine authorizationVaccine looksBrianna keilar